SPAC Swiftmerge Acquisition Corp. (IVCP) has agreed to merge with with HDL Therapeutics through a deal that estimates the enterprise value at around $480M. Read more here.
MedTech Acquisition Corp. (MTAC) shareholders have voted in favor of the SPAC's planned merger with oncology products developer TriSalus Life Sciences. Read more here.
TriSalus Life Sciences® Inc., an oncology company in the process of going public through a business combination transaction with MedTech Acquisition Corporation , today announced new Phase 1... | April 20, 2023